Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuralgia 1 Head and Neck Neoplasms 1 Breast Neoplasms 1 Breast Cancer Patient 1 Agnosia 1

Interventions

pembrolizumab 27 Cisplatin 18 Cetuximab 12 Carboplatin 12 Surveys and Questionnaires 8 Radiotherapy 8 Paclitaxel 8 Docetaxel 6 Radiotherapy, Intensity-Modulated 5 Surgical Procedures, Operative 4 dostarlimab 3 Therapeutics 3 Standard of Care 3 Fluorouracil 3 Cyclophosphamide 3 Chemoradiotherapy 3 Blood Specimen Collection 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 toripalimab 2 nimotuzumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 abemaciclib 2 X-Rays 2 Taxes 2 Radiosurgery 2 Radiation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Capsaicin × 90 days × Clear all

NCT04704453 2026-04-14

TEC-ORL

Institut Claudius Regaud

Phase 2 Completed

Head and Neck Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡